| Literature DB >> 25826337 |
Zhi-Qiang Cai1, Shu-Bin Si2, Chen Chen3, Yaling Zhao4, Yong-Yi Ma3, Lin Wang3, Zhi-Min Geng3.
Abstract
BACKGROUND: The prognosis of hepatocellular carcinoma (HCC) after hepatectomy involves many factors. Previous studies have evaluated the separate influences of single factors; few have considered the combined influence of various factors. This paper combines the Bayesian network (BN) with importance measures to identify key factors that have significant effects on survival time.Entities:
Mesh:
Year: 2015 PMID: 25826337 PMCID: PMC4380349 DOI: 10.1371/journal.pone.0120805
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Standard description of data.
| ID | Variables | General description | Values | Type |
|---|---|---|---|---|
| 1 | Sex | Female | 0 | Discrete |
| Male | 1 | |||
| 2 | Age | 16~45,46~59,60~84(years) | Continuous | |
| 3 | HBV history | N | 0 | Discrete |
| Y | 1 | |||
| 4 | HCV history | N | 0 | Discrete |
| Y | 1 | |||
| 5 | Preoperative AFP | 0~8,8.01~399.99,400~121000(ng/mL) | Continuous | |
| 6 | Preoperative liver function | Child A | 0 | Discrete |
| Child B | 1 | |||
| 7 | Tumor size | 0.8~1.9,2~4.9,5~9.9,≥10(cm) | Continuous | |
| 8 | Tumor number | Single | 0 | Discrete |
| Multi | 1 | |||
| 9 | PVTT | N | 0 | Discrete |
| Y | 1 | |||
| 10 | Operative method | PAH | 0 | Discrete |
| ANH | 1 | |||
| 11 | Cancer metastasis | N | 0 | Discrete |
| Y | 1 | |||
| 12 | TCPH | < = 15 mins | 0 | Discrete |
| >15 mins | 1 | |||
| 13 | Intraoperative blood loss | < = 400 ml | 0 | Discrete |
| >400 ml | 1 | |||
| 14 | Postoperative complication | N | 0 | Discrete |
| Y | 1 | |||
| 15 | Postoperative TACE | N | 0 | Discrete |
| Y | 1 | |||
| 16 | Survival time | 1~10,11~68(months) | Continuous |
Fig 1BN model for prognostic factors.
Confusion matrix for a binary classification problem.
| Actual | |||
|---|---|---|---|
| Positive | Negative | ||
| Predicted | Positive | True Positive (TP) | False Positive(FP) |
| Negative | False Negative(FN) | True Negative(TN) | |
Fig 2(A) Overall survival of HCC patients after hepatectomy. (B) Survival between HCC with PVTT and without PVTT. (C) Survival between HCC with curative resection and palliative resection.
Confusion matrix and reliability and accuracy of the BN model of prognosis.
| Survival time(n) | < = 10m (n = 150) | >10m (n = 149) | |
|---|---|---|---|
| Confusion matrix(n) | < = 10m (102) | 77 | 25 |
| >10m (197) | 73 | 124 | |
| Reliability(%) | < = 10m (102) | 75.49% | 24.51% |
| >10m (197) | 37.06% | 62.94% | |
| Accuracy(%) | < = 10m (102) | 51.33% | 16.78% |
| >10m (197) | 48.67% | 83.22% |
Fig 3ROC curve of a survival time of >10 months.
Importance of prognostic factors in survival time ranking.
| Prognostic factors | State | Priori probability p(Vi) | Posterior probability p(S = 0|Vi = j) | FVi | MFVi | Rank 1 | Person correlation | Rank 2 |
|---|---|---|---|---|---|---|---|---|
| Sex | 0 | 0.194 | 0.5172 | -0.0309 | 0.0385 | 14 | 0.0153 | 14 |
| 1 | 0.806 | 0.4979 | 0.0076 | |||||
| Age | 16–45 | 0.3311 | 0.5051 | -0.0068 | 0.0068 | 15 | 0.0041 | 15 |
| 45–60 | 0.408 | 0.5 | 0.0034 | |||||
| 60–84 | 0.2609 | 0.5 | 0.0034 | |||||
| HBV history | 0 | 0.2341 | 0.5429 | -0.0821 | 0.1072 | 13 | 0.0455 | 12 |
| 1 | 0.7659 | 0.4891 | 0.0251 | |||||
| HCV history | 0 | 0.9465 | 0.5159 | -0.0283 | 0.53 | 6 | 0.1197 | 9 |
| 1 | 0.0535 | 0.25 | 0.5017 | |||||
| Preoperative AFP | 0–8 | 0.184 | 0.4 | 0.2027 | 0.1468 | 12 | -0.0251 | 13 |
| 8–400 | 0.4147 | 0.5323 | -0.061 | |||||
| 400–121000 | 0.4013 | 0.5167 | -0.0299 | |||||
| Preoperative liver function | 0 | 0.8194 | 0.4816 | 0.0401 | 0.2212 | 11 | -0.0854 | 10 |
| 1 | 0.1806 | 0.5926 | -0.1812 | |||||
| Tumor size | 0 | 0.0201 | 0.1667 | 0.6677 | 0.4663 | 7 | -0.2044 | 5 |
| 1 | 0.4849 | 0.4 | 0.2027 | |||||
| 2 | 0.301 | 0.5444 | -0.0851 | |||||
| 3 | 0.194 | 0.7241 | -0.4433 | |||||
| Tumor number | 0 | 0.8328 | 0.4498 | 0.1034 | 0.6183 | 4 | -0.2315 | 3 |
| 1 | 0.1672 | 0.76 | -0.5148 | |||||
| PVTT | 0 | 0.9164 | 0.4708 | 0.0616 | 0.7359 | 1 | -0.2628 | 1 |
| 1 | 0.0836 | 0.84 | -0.6743 | |||||
| Operative | 0 | 0.1304 | 0.8205 | -0.6354 | 0.7309 | 2 | 0.247 | 2 |
| Method | 1 | 0.8696 | 0.4538 | 0.0955 | ||||
| Cancer metastasis | 0 | 0.8462 | 0.4585 | 0.0861 | 0.5593 | 5 | -0.2025 | 6 |
| 1 | 0.1538 | 0.7391 | -0.4732 | |||||
| TCPH | 0 | 0.4749 | 0.3803 | 0.242 | 0.4608 | 3 | -0.2309 | 4 |
| 1 | 0.5251 | 0.6115 | -0.2189 | |||||
| Intraoperative blood loss | 0 | 0.4783 | 0.4196 | 0.1636 | 0.3135 | 9 | -0.1572 | 8 |
| 1 | 0.5217 | 0.5769 | -0.1499 | |||||
| Postoperative complication | 0 | 0.5385 | 0.4658 | 0.0716 | 0.1549 | 10 | -0.0774 | 11 |
| 1 | 0.4615 | 0.5435 | -0.0833 | |||||
| Postoperative TACE | 0 | 0.5351 | 0.5937 | -0.1834 | 0.3947 | 8 | 0.1976 | 7 |
| 1 | 0.4649 | 0.3957 | 0.2113 |
The posterior probability of survival time for patients with PVTT.
| Metastasis | Blood loss | TCPH | Tumor number | Survival time | ||
|---|---|---|---|---|---|---|
| PVTT = 1 | PAH | P(1) = 51.53% | P(1) = 68.87% | P(1) = 84.95% | P(1) = 48.47% | P(>10) = 7.14% |
| ANH | P(1) = 12.44% | P(1) = 66.62% | P(1) = 82.79% | P(1) = 15.48% | P(>10) = 27.27% |
Simulation to prolong the survival time of patients with PVTT.
| Operative methods | Survival time | |||||
|---|---|---|---|---|---|---|
| PVTT = 1 | Tumor Number = 1 | TACE = 1 | Blood loss = 0 | TCPH = 1 | PAH | P(>10) = 11.15% |
| ANH | P(>10) = 28.8% |